Volver
Bladder cancer most often begins in the cells (urothelial cells) that line the inside of the bladder.
Most bladder cancers are diagnosed at an early stage, when the cancer is highly treatable. But even early-stage bladder cancers can come back after successful treatment.
In most cases, the presence of blood in urine (hematuria) is the first sign of bladder cancer.
Sometimes, it can cause changes when urinating, such as:
- Urinating more often than usual
- Pain or burning when urinating
- Feeling that you need to urinate right away, even when your bladder is not full
- Having trouble urinating or having a weak flow of urine
- Having to get up to urinate many times during the night
Carcivac
See more
Carcivac is an immunotherapy indicated for the treatment of Flat urothelial carcinoma in situ of the bladder.
It is also indicated as adjuvant therapy of the transurethral resection of the noninvasive papillary tumor, either superficial, primary or recurrent, restricted to the mucosa of the bladder (Stage Ta or T1). Intravesical inmonotherapy with BCG has been proven to reduce the tumor for recurring and prevents progression.
Presentation: 3 vials x 40 mg/vial.
Carcivac - Dosing